Want to join the conversation?
$MCD 2Q15 Call: Looking ahead to 3Q15, expect positive global comparable sales led by growth in the newly-created International Lead Market segment and China's continuing recovery from the 2014 APMEA supplier issue. Australia, Canada and the UK continue to deliver strong performance and France is gaining share despite the challenging headwinds.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.